Background Background Major depression is an
Major depression is an important and costly problem among important and costly problem among adolescents, yet evidence to supportthe adolescents, yet evidence to supportthe provision of cost-effective treatments is provision of cost-effective treatments is lacking. lacking.
Aims
Aims To assess the short-term cost-To assess the short-term costeffectiveness of combined selective effectiveness of combined selective serotonin reuptake inhibitors (SSRIs) and serotonin reuptake inhibitors (SSRIs) and cognitive^behavioural therapy (CBT) cognitive^behavioural therapy (CBT) together with clinical care compared with together with clinical care compared with SSRIs and clinical care alone in adolescents SSRIs and clinical care alone in adolescents with major depression. with major depression.
Method Method Pragmatic randomised
Pragmatic randomised controlled trial in the UK. Outcomes and controlled trial in the UK. Outcomes and costs were assessed at baseline,12 and costs were assessed at baseline,12 and 28 weeks. 28 weeks.
Results
Results The trial comprised 208
The trial comprised 208 adolescents, aged11^17 years, with major adolescents, aged11^17 years, with major or probable major depressionwho had not or probable major depressionwho had not responded to a brief initial psychosocial responded to a brief initial psychosocial intervention.There were no significant intervention.There were no significant differences in outcome between the differences in outcome between the groups with and without CBT. Costs were groups with and without CBT. Costs were higher in the group with CBT, although not higher in the group with CBT, although not significantly so ( significantly so (P P¼0.057). Cost-0.057). Costeffectiveness analysis and exploration of effectiveness analysis and exploration of the associated uncertainty suggestthere is the associated uncertainty suggestthere is less than a 30% probability that CBT plus less than a 30% probability that CBT plus SSRIs is more cost-effective than SSRIs SSRIs is more cost-effective than SSRIs alone. alone.
Conclusions Conclusions A combination of CBT
A combination of CBT plus SSRIs is not more cost-effective in the plus SSRIs is not more cost-effective in the short-term than SSRIs alone for treating short-term than SSRIs alone for treating adolescents with major depression in adolescents with major depression in receipt of routine specialist clinical care. receipt of routine specialist clinical care.
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Major depression among adolescents is an Major depression among adolescents is an important and costly problem but evidence important and costly problem but evidence to support cost-effective treatments is to support cost-effective treatments is lacking (Romeo lacking (Romeo et al et al, 2005) . This paper re-, 2005) . This paper reports an economic evaluation of cognitive-ports an economic evaluation of cognitivebehavioural therapy (CBT) plus selective behavioural therapy (CBT) plus selective serotonin reuptake inhibitors (SSRIs) com-serotonin reuptake inhibitors (SSRIs) compared with SSRIs alone within a random-pared with SSRIs alone within a randomised controlled superiority trial -the ised controlled superiority trial -the Adolescent Depression Antidepressant and Adolescent Depression Antidepressant and Psychotherapy Trial (ADAPT; Goodyer Psychotherapy Trial (ADAPT; Goodyer et et al al, 2007) . It is currently unclear whether , 2007) . It is currently unclear whether combination therapy is more effective than combination therapy is more effective than monotherapy, as studies from the USA are monotherapy, as studies from the USA are conflicting (Clarke conflicting (Clarke et al et al, 2005; Melvin , 2005; Melvin et et al al, 2006) , and there have been no UK trials , 2006) , and there have been no UK trials in a typical National Health Service (NHS) in a typical National Health Service (NHS) population. The provision of combination population. The provision of combination therapy, should it prove effective, would therapy, should it prove effective, would necessitate a shift in resources that could necessitate a shift in resources that could be used elsewhere. Consequently, the cost-be used elsewhere. Consequently, the costeffectiveness of CBT plus SSRIs should be effectiveness of CBT plus SSRIs should be determined. determined.
METHOD METHOD

Hypothesis Hypothesis
The aim of the ADAPT trial was to deter-The aim of the ADAPT trial was to determine, in a routine sample of adolescents mine, in a routine sample of adolescents with depression referred to child and with depression referred to child and adolescent mental health services, whether adolescent mental health services, whether combination therapy (CBT plus SSRIs) combination therapy (CBT plus SSRIs) was more effective and more cost-effective was more effective and more cost-effective than SSRIs alone when provided in addition than SSRIs alone when provided in addition to routine specialist clinical care. We to routine specialist clinical care. We hypothesised that the additional costs of hypothesised that the additional costs of CBT would be offset by improvements in CBT would be offset by improvements in patient outcomes and/or savings in the use patient outcomes and/or savings in the use of other services, compared with SSRI of other services, compared with SSRI treatment alone. Given the focus on patient treatment alone. Given the focus on patient outcomes, we considered a cost-effective-outcomes, we considered a cost-effectiveness analysis to be the most appropriate ness analysis to be the most appropriate method of economic evaluation. method of economic evaluation.
Trial design Trial design
Adolescents aged 11-17 years meeting Adolescents aged 11-17 years meeting DSM-IV criteria (American Psychiatric DSM-IV criteria (American Psychiatric Association, 1994) for major or probable Association, 1994) for major or probable major depression were recruited to this major depression were recruited to this multicentre randomised controlled trial in multicentre randomised controlled trial in Manchester and Cambridge, UK between Manchester and Cambridge, UK between June 2000 and November 2004 . A brief June 2000 and November 2004 . A brief psychosocial intervention was undertaken psychosocial intervention was undertaken pre-randomisation to exclude participnats pre-randomisation to exclude participnats with depression that remit rapidly. with depression that remit rapidly. Randomisation was carried out by a remote Randomisation was carried out by a remote independent statistical centre. Stochastic independent statistical centre. Stochastic minimisation was used to ensure balance minimisation was used to ensure balance on severity, centre, gender, comorbid be-on severity, centre, gender, comorbid behavioural disorder and age. More detailed havioural disorder and age. More detailed information on the brief initial intervention information on the brief initial intervention and all other aspects of the design of this and all other aspects of the design of this trial are provided by Goodyer trial are provided by Goodyer et al et al (2007 Goodyer et al et al ( ). (2007 .
Interventions Interventions
Fluoxetine was chosen as the primary SSRI Fluoxetine was chosen as the primary SSRI as it was the only SSRI with evidence for as it was the only SSRI with evidence for efficacy from a randomised controlled trial efficacy from a randomised controlled trial at the start of the study (Emslie at the start of the study (Emslie et al et al, 1997) . , 1997). If fluoxetine was ineffective or causing If fluoxetine was ineffective or causing problematic side effects, other SSRIs were problematic side effects, other SSRIs were considered. All participants were seen regu-considered. All participants were seen regularly by a study psychiatrist for general case larly by a study psychiatrist for general case management and monitoring of medi-management and monitoring of medication. Participants receiving SSRIs only cation. Participants receiving SSRIs only were offered nine out-patient sessions over were offered nine out-patient sessions over 28 weeks; this could be increased depend-28 weeks; this could be increased depending on clinical need. Participants in the ing on clinical need. Participants in the combined therapy group were also offered combined therapy group were also offered weekly CBT for 12 weeks, followed by six weekly CBT for 12 weeks, followed by six maintenance sessions every 2 weeks and maintenance sessions every 2 weeks and a final session at 28 weeks. CBT was pro-a final session at 28 weeks. CBT was provided by psychiatrists (who also under-vided by psychiatrists (who also undertook case management and monitoring of took case management and monitoring of medication) or CBT therapists (in which medication) or CBT therapists (in which case separate sessions with a study psy-case separate sessions with a study psychiatrist were provided for case manage-chiatrist were provided for case management and monitoring of medication). All ment and monitoring of medication). All therapists had reached pre-agreed compe-therapists had reached pre-agreed competence criteria and supervision was provided tence criteria and supervision was provided by fully accredited CBT supervisors. by fully accredited CBT supervisors.
Outcome measures Outcome measures
Research assessors, masked to treatment al-Research assessors, masked to treatment allocation, carried out assessments at base-location, carried out assessments at baseline, 6, 12 and 28 weeks after trial entry. line, 6, 12 and 28 weeks after trial entry. , 1999) , a global measure of , 1999), a global measure of mental health impairment scored in the mental health impairment scored in the range 0-52 (with higher scores indicating range 0-52 (with higher scores indicating worse outcomes). Secondary analyses ex-worse outcomes). Secondary analyses explored cost-effectiveness in terms of qual-plored cost-effectiveness in terms of quality-adjusted life-years (QALYs), calculated ity-adjusted life-years (QALYs), calculated using the EQ-5D measure of health-related using the EQ-5D measure of health-related quality of life (Williams, 1995; Brooks, quality of life (Williams, 1995; Brooks, 1996 ). This 1996 . This method of economic evaluation method of economic evaluation is known as cost-utility analysis. The EQ-is known as cost-utility analysis. The EQ-5D consists of a five-item questionnaire in 5D consists of a five-item questionnaire in the domains of mobility, self-care, usual ac-the domains of mobility, self-care, usual activities, pain/ tivities, pain/discomfort and anxiety/depres-discomfort and anxiety/depression, which classifies individuals into one of sion, which classifies individuals into one of 243 health states, each associated with a 243 health states, each associated with a score that can be used to calculate QALYs. score that can be used to calculate QALYs. In addition, it contains a visual analogue In addition, it contains a visual analogue scale (VAS) on which patients rate their scale (VAS) on which patients rate their own health between 0 (worst imaginable own health between 0 (worst imaginable health state) and 100 (best imaginable health state) and 100 (best imaginable health state). The measure has been used health state). The measure has been used extensively and its psychometric properties extensively and its psychometric properties are adequate (Brooks, 1996) . are adequate (Brooks, 1996) .
Cost Cost
The economic evaluation took a broad The economic evaluation took a broad service-providing perspective, including that service-providing perspective, including that of the health, social services, education, of the health, social services, education, voluntary and private sectors. Travel costs voluntary and private sectors. Travel costs to intervention sessions and productivity to intervention sessions and productivity losses of the primary carer resulting from losses of the primary carer resulting from their child's illness were also recorded. their child's illness were also recorded. Economic information was collected by Economic information was collected by interview at baseline, 12 and 28 weeks interview at baseline, 12 and 28 weeks using the Child and Adolescent Service Use using the Child and Adolescent Service Use Schedule (CA-SUS), developed by the Schedule (CA-SUS), developed by the authors in previous studies and adapted for authors in previous studies and adapted for this study (Byford this study (Byford et al et al, 1999; Harrington , 1999; Harrington et al et al, 2000; Barrett , 2000; Barrett et al et al, 2006) . At baseline, , 2006 ). At baseline, information covered the previous 6 months. information covered the previous 6 months. At follow-up, service use since the previous At follow-up, service use since the previous interview was recorded. Data on the trial interview was recorded. Data on the trial interventions, CBT and case management/ interventions, CBT and case management/ monitoring of medication were collected monitoring of medication were collected from clinical records to avoid patients re-from clinical records to avoid patients revealing their treatment group to the re-vealing their treatment group to the research assessors. All unit costs were for search assessors. All unit costs were for the financial year 2003-04, the most recent the financial year 2003-04, the most recent financial year over which the trial data financial year over which the trial data were collected, and are reported in UK were collected, and are reported in UK pounds sterling. Discounting was not neces-pounds sterling. Discounting was not necessary owing to the short-term nature of the sary owing to the short-term nature of the trial. trial.
Intervention sessions were costed on the Intervention sessions were costed on the basis of the salary of the professional in-basis of the salary of the professional involved. Costs included relevant on-costs volved. Costs included relevant on-costs (employers' national insurance and super-(employers' national insurance and superannuation contributions) and overheads annuation contributions) and overheads (administrative, managerial and capital; (administrative, managerial and capital; Curtis & Netten, 2004) . Intervention ses- Curtis & Netten, 2004) . Intervention sessions lasted approximately 55 min for the sions lasted approximately 55 min for the CBT plus SSRIs group and 30 min for the CBT plus SSRIs group and 30 min for the SSRIs group. Indirect time was included SSRIs group. Indirect time was included using information provided by the trial using information provided by the trial therapists on the ratio of direct face-to-face therapists on the ratio of direct face-to-face contact to all other activities. Although the contact to all other activities. Although the time the therapists spent in supervision is time the therapists spent in supervision is included in these calculations, supervisor included in these calculations, supervisor costs were excluded owing to difficulties costs were excluded owing to difficulties in accurately separating supervision for in accurately separating supervision for the two trial groups. Supervisor costs were the two trial groups. Supervisor costs were estimated and explored in sensitivity estimated and explored in sensitivity analysis. Intervention costs were calculated analysis. Intervention costs were calculated on the basis of the number of sessions on the basis of the number of sessions attended; the inclusion of the cost of non-attended; the inclusion of the cost of nonattendance was explored in sensitivity ana-attendance was explored in sensitivity analysis. The cost of the initial clinical lysis. The cost of the initial clinical assessment and brief pre-randomisation assessment and brief pre-randomisation intervention were not included, as these intervention were not included, as these activities took place before randomisation. activities took place before randomisation.
Costs of SSRIs and other psychotropic Costs of SSRIs and other psychotropic medication were taken from the medication were taken from the British British National Formulary National Formulary ( Council, 2005) . Productivity losses of the primary carer were calculated losses of the primary carer were calculated using the human capital approach, which using the human capital approach, which involves multiplying days off work owing involves multiplying days off work owing to illness by the individual's salary. to illness by the individual's salary.
Statistical methods Statistical methods
Analyses were carried out on an intention-Analyses were carried out on an intentionto-treat basis using a statistical analysis to-treat basis using a statistical analysis plan drawn up prior to data analysis. The plan drawn up prior to data analysis. The analyses were conducted as for a superior-analyses were conducted as for a superiority trial with CBT plus SSRIs as the default ity trial with CBT plus SSRIs as the default (superior). Although costs were not nor-(superior). Although costs were not normally distributed, analyses compared mean mally distributed, analyses compared mean costs using standard parametric costs using standard parametric t t-tests with -tests with the validity of results confirmed using the validity of results confirmed using bootstrapping (Efron & Tibshirani, 1993; bootstrapping (Efron & Tibshirani, 1993; . The primary . The primary analysis was of total cost per young person analysis was of total cost per young person over 28 weeks. Multiple regression was over 28 weeks. Multiple regression was used to adjust for the following pre-speci-used to adjust for the following pre-specified baseline characteristics: gender, age, fied baseline characteristics: gender, age, centre, HoNOSCA score, severity of illness centre, HoNOSCA score, severity of illness (Children's Global Assessment Scale; (Children's Global Assessment Scale; Shaffer Shaffer et al et al, 1983) , comorbid behavioural , 1983), comorbid behavioural disorder (K-SADS-PL) and costs, in all disorder (K-SADS-PL) and costs, in all tests of differences in costs and outcomes. tests of differences in costs and outcomes. The impact of drop-out was assessed by The impact of drop-out was assessed by comparing baseline characteristics of parti-comparing baseline characteristics of participants with and without full economic cipants with and without full economic data. Subgroup analyses by centre and data. Subgroup analyses by centre and severity of illness were performed using severity of illness were performed using tests of interaction. tests of interaction.
Cost-effectiveness was explored Cost-effectiveness was explored through the calculation of incremental through the calculation of incremental cost-effectiveness ratios (ICER), defined as cost-effectiveness ratios (ICER), defined as the difference in mean costs divided by the difference in mean costs divided by difference in mean effects (Van Hout difference in mean effects (Van Hout et al et al, , 1994) . Non-parametric bootstrapping (re-1994) . Non-parametric bootstrapping (repeat re-sampling) from the costs and effec-peat re-sampling) from the costs and effectiveness data was used to generate a joint tiveness data was used to generate a joint distribution of incremental mean costs and distribution of incremental mean costs and effects for the two treatments (Efron & effects for the two treatments (Efron & Tibshirani, 1993) . This was then used to Tibshirani, 1993) . This was then used to calculate the probability that each of the calculate the probability that each of the treatments is the optimal choice, subject treatments is the optimal choice, subject to a range of possible maximum values to a range of possible maximum values (ceiling ratio) that a decision-maker might (ceiling ratio) that a decision-maker might be willing to pay for a unit improvement be willing to pay for a unit improvement in outcome. Cost-effectiveness acceptability in outcome. Cost-effectiveness acceptability curves are presented by plotting these curves are presented by plotting these probabilities for a range of possible values probabilities for a range of possible values of the ceiling ratio (Fenwick of the ceiling ratio (Fenwick et al et al, 2001) . , 2001). These curves incorporate the uncertainty These curves incorporate the uncertainty that exists around the estimates of expected that exists around the estimates of expected costs and expected effects associated with costs and expected effects associated with the two interventions (Fenwick & Byford, the two interventions (Fenwick & Byford, 2005) . 2005).
RESULTS
Participants Participants
In total 208 adolescents were randomised In total 208 adolescents were randomised to CBT plus SSRIs ( to CBT plus SSRIs (n n¼105) or SSRIs alone 105) or SSRIs alone ( (n n¼103). Full economic data were available 103). Full economic data were available for 188 participants (90%), 96 in the CBT for 188 participants (90%), 96 in the CBT plus SSRIs group and 92 in the SSRIs plus SSRIs group and 92 in the SSRIs group. Comparison of baseline characteris-group. Comparison of baseline characteristics revealed a significant centre difference tics revealed a significant centre difference between those included in the economic between those included in the economic evaluation and those who were missing, evaluation and those who were missing, with 95% of missing data coming from with 95% of missing data coming from Manchester ( Manchester (P P¼0.015). No other signifi-0.015). No other significant differences were found and there was cant differences were found and there was no difference in missing data between the no difference in missing data between the two treatment groups. Although final two treatment groups. Although final follow-up was planned to take place 28 follow-up was planned to take place 28 weeks after trial entry, this was not always weeks after trial entry, this was not always achieved. Attempts were made to include achieved. Attempts were made to include all participants, so earlier and longer all participants, so earlier and longer follow-ups were allowed. For this reason, follow-ups were allowed. For this reason, length of follow-up varied greatly (range length of follow-up varied greatly (range 21-51 weeks); however, there was no 21-51 weeks); however, there was no significant difference between the two significant difference between the two treatment groups (mean 29 weeks in both treatment groups (mean 29 weeks in both groups). In addition, there were no signifi-groups). In addition, there were no significant differences in baseline characteristics cant differences in baseline characteristics between the two treatment groups (Table 1) . between the two treatment groups (Table 1) .
Outcomes Outcomes
Results for the HoNOSCA and EQ-5D at Results for the HoNOSCA and EQ-5D at the 28-week follow-up are reported in Ta-the 28-week follow-up are reported in Table 2. The two groups did not differ signif-ble 2. The two groups did not differ significantly on either measure, nor were any icantly on either measure, nor were any differences found at the 12-week follow-differences found at the 12-week followup (Goodyer up (Goodyer et al et al, 2007) . EQ-5D utilities , 2007) . EQ-5D utilities and self-rated health status from the visual and self-rated health status from the visual analogue scale show improvements in analogue scale show improvements in health status over time in both groups, health status over time in both groups, but there was little difference between the but there was little difference between the two groups at final follow-up. two groups at final follow-up. Table 3 details the mean number of con- Table 3 details the mean number of contacts participants had with all services over tacts participants had with all services over the 28-week follow-up. Resource use dif-the 28-week follow-up. Resource use differed little between the two groups except fered little between the two groups except for intervention sessions and in-patient for intervention sessions and in-patient services, with the CBT plus SSRIs group services, with the CBT plus SSRIs group attending more intervention sessions and attending more intervention sessions and spending more time in hospital than the spending more time in hospital than the SSRIs group. SSRIs group.
Resource use Resource use
Costs Costs
The mean cost of intervention sessions for The mean cost of intervention sessions for the CBT plus SSRIs group was estimated the CBT plus SSRIs group was estimated to be £67 (range £41-£216 depending on to be £67 (range £41-£216 depending on profession and seniority of therapist), com-profession and seniority of therapist), compared with £36 for the SSRIs group (range pared with £36 for the SSRIs group (range £22-£118). Assuming full attendance, the £22-£118). Assuming full attendance, the cost of a full course of CBT plus SSRIs cost of a full course of CBT plus SSRIs was estimated to be £1273 (range £779-was estimated to be £1273 (range £779-£4104). The actual cost per study partici-£4104). The actual cost per study participant was £750 since few completed the full pant was £750 since few completed the full course of treatment owing to non-atten-course of treatment owing to non-attendance or a clinical decision to discharge dance or a clinical decision to discharge the participant. the participant. Table 4 details the total costs over the Table 4 details the total costs over the 28-week follow-up. Results from the non-28-week follow-up. Results from the nonparametric bootstrap replications did not parametric bootstrap replications did not differ substantially from the parametric differ substantially from the parametric results and are not reported here. Total results and are not reported here. Total costs per participant in the CBT plus SSRIs costs per participant in the CBT plus SSRIs group were £6940, which was £2300 more group were £6940, which was £2300 more than in the SSRIs group. This difference than in the SSRIs group. This difference was not statistically significant but came was not statistically significant but came close ( close (P P¼0.057). The CBT plus SSRIs 0.057). The CBT plus SSRIs group incurred significantly greater costs group incurred significantly greater costs than the SSRIs group in terms of inter-than the SSRIs group in terms of intervention sessions and secondary healthcare vention sessions and secondary healthcare services. The difference for intervention services. The difference for intervention sessions was due to the greater length of sessions was due to the greater length of these sessions and higher attendance rates these sessions and higher attendance rates in the CBT plus SSRIs group. The latter in the CBT plus SSRIs group. The latter difference was owing primarily to two difference was owing primarily to two participants in the CBT plus SSRIs group participants in the CBT plus SSRIs group who were admitted to hospital for a signif-who were admitted to hospital for a significant proportion of their time in the trial icant proportion of their time in the trial (65% and 92%, respectively). Differences (65% and 92%, respectively). Differences between the two groups were almost between the two groups were almost entirely due to differences in the cost of entirely due to differences in the cost of admissions. To take into consideration the admissions. To take into consideration the variable length of follow-up costs per week variable length of follow-up costs per week are also reported but this made no differ-are also reported but this made no difference to the results ( ence to the results (P P¼0.059). In subgroup 0.059). In subgroup analyses, there were no statistically signifi-analyses, there were no statistically significant differences in the estimated effect of cant differences in the estimated effect of CBT plus SSRIs on total cost by centre (test CBT plus SSRIs on total cost by centre (test of interaction of interaction P P¼0.412) or severity of 0.412) or severity of illness ( illness (P P¼0.971). 0.971).
Sensitivity analysis Sensitivity analysis
A number of one-way sensitivity analyses A number of one-way sensitivity analyses were undertaken. were undertaken.
(a) (a) The cost of intervention sessions was
The cost of intervention sessions was based on the salaries of the profes-based on the salaries of the professionals involved. Since the seniority of sionals involved. Since the seniority of the therapists may have been influenced the therapists may have been influenced by the research, these costs were re-by the research, these costs were recalculated to reflect likely clinical prac-calculated to reflect likely clinical practice using the following professionals: tice using the following professionals: specialist registrar, clinical psychologist specialist registrar, clinical psychologist grade A and mental health nurse grade grade A and mental health nurse grade
The main analysis excluded sessions The main analysis excluded sessions where the participant did not attend, where the participant did not attend, which assumes the therapist was able which assumes the therapist was able to use the time for alternative produc-to use the time for alternative productive work. This assumption was tive work. This assumption was removed and the full cost of parti-removed and the full cost of participants not attending was included cipants not attending was included (equivalent to the cost of an attended (equivalent to the cost of an attended session). session).
(c) (c) Estimates of the cost of supervisors' Estimates of the cost of supervisors' time was added on the basis of the time was added on the basis of the following assumptions: supervision following assumptions: supervision provided by a consultant psychiatrist; provided by a consultant psychiatrist; 5 2 3 5 2 3 AUTHOR'S PROOF AUTHOR'S PROOF mean of ten intervention sessions per mean of ten intervention sessions per week; mean of 60 min of supervision week; mean of 60 min of supervision per week; mean of 6 min of supervision per week; mean of 6 min of supervision per session per week. per session per week.
(d) (d) The impact on cost of the two parti-The impact on cost of the two participants who spent the majority of the cipants who spent the majority of the trial in hospital was explored by trial in hospital was explored by excluding these from the analysis. excluding these from the analysis.
(e) (e) Travel and productivity losses borne by
Travel and productivity losses borne by parents were added to provide a parents were added to provide a broader cost perspective. broader cost perspective.
(f) (f) Local costs were changed to national Local costs were changed to national unit costs (Curtis & Netten, 2004) to unit costs (Curtis & Netten, 2004) to assess generalisability to the wider UK assess generalisability to the wider UK population. population.
The majority of these analyses did not The majority of these analyses did not alter the finding of no significant difference alter the finding of no significant difference in cost between the two groups (Table 5 ). in cost between the two groups ( Table 5 ).
Inclusion of the full cost of a participant
Inclusion of the full cost of a participant not attending and supervisors' time in-not attending and supervisors' time increased the difference in cost between the creased the difference in cost between the two groups to the extent that the CBT plus two groups to the extent that the CBT plus SSRIs group became significantly more ex-SSRIs group became significantly more expensive than the SSRIs group ( pensive than the SSRIs group (P P¼0.049 in 0.049 in both analyses). The removal of the parti-both analyses). The removal of the participants who spent most of the trial in cipants who spent most of the trial in hospital greatly reduced the difference in hospital greatly reduced the difference in cost ( cost (P P¼0.202). 0.202).
Cost-effectiveness analysis Cost-effectiveness analysis
Using the bootstrapped means, the CBT Using the bootstrapped means, the CBT plus SSRIs group cost £2327 more than plus SSRIs group cost £2327 more than the SSRIs group and HoNOSCA scores the SSRIs group and HoNOSCA scores were 0.81 points worse over 28 weeks, were 0.81 points worse over 28 weeks, giving an ICER of £2873 per unit increase giving an ICER of £2873 per unit increase in HoNOSCA score, where higher scores in HoNOSCA score, where higher scores indicate worse outcomes. Figure 1 presents indicate worse outcomes. Figure 1 presents a scatterplot of the bootstrapped replica-a scatterplot of the bootstrapped replications for incremental cost and incremental tions for incremental cost and incremental HoNOSCA score on the cost-effectiveness HoNOSCA score on the cost-effectiveness plane. Because poorer outcomes on the plane. Because poorer outcomes on the HoNOSCA are associated with higher HoNOSCA are associated with higher scores, moving from left to right on the scores, moving from left to right on the x x-axis means a worsening in the incremental axis means a worsening in the incremental effectiveness for the CBT plus SSRIs group effectiveness for the CBT plus SSRIs group compared with the SSRIs group. The stand-compared with the SSRIs group. The standard cost-effectiveness plane is therefore re-ard cost-effectiveness plane is therefore reversed. In the north-west quadrant, the versed. In the north-west quadrant, the experimental intervention is more costly experimental intervention is more costly and more effective, whereas in the north-and more effective, whereas in the northeast quadrant the experimental intervention east quadrant the experimental intervention is more costly and less effective. The is more costly and less effective. The scatterplot demonstrates that CBT plus scatterplot demonstrates that CBT plus SSRIs is more expensive than SSRIs for SSRIs is more expensive than SSRIs for almost all replications (points above the almost all replications (points above the x x-axis) and is associated with poorer out-axis) and is associated with poorer outcomes for a large proportion of replications comes for a large proportion of replications (points to the left of the (points to the left of the y y-axis). Figure 2 -axis). Figure 2 illustrates the associated uncertainty. At a illustrates the associated uncertainty. At a ceiling ratio of £50 000, the highest value ceiling ratio of £50 000, the highest value shown, there is a 25% chance of CBT plus shown, there is a 25% chance of CBT plus SSRIs being more cost-effective than SSRIs SSRIs being more cost-effective than SSRIs alone. Tests beyond this value (up to a ceil-alone. Tests beyond this value (up to a ceiling ratio of £150 000) found that the pro-ing ratio of £150 000) found that the probability of CBT plus SSRIs being more bability of CBT plus SSRIs being more cost-effective than SSRIs alone did not rise cost-effective than SSRIs alone did not rise above 26%. above 26%.
The relationship was similar for The relationship was similar for QALYs, with the CBT plus SSRIs group QALYs, with the CBT plus SSRIs group having higher costs and lower effects than having higher costs and lower effects than the SSRIs group (bootstrapped incremental the SSRIs group (bootstrapped incremental mean costs £2364; bootstrapped incremen-mean costs £2364; bootstrapped incremental mean effects tal mean effects 7 70.023), with an ICER of 0.023), with an ICER of 7 7£102 965, where higher scores indicate £102 965, where higher scores indicate better outcomes. The cost-effectiveness better outcomes. The cost-effectiveness acceptability curve showing the probability acceptability curve showing the probability of CBT plus SSRIs being more cost-effective of CBT plus SSRIs being more cost-effective than SSRIs alone did not rise above 4%. than SSRIs alone did not rise above 4%.
DISCUSSION DISCUSSION
Outcomes Outcomes
The combination of CBT with SSRIs did The combination of CBT with SSRIs did not result in significant clinical benefits not result in significant clinical benefits for adolescents with major depression com-for adolescents with major depression compared with SSRIs alone over 28 weeks. pared with SSRIs alone over 28 weeks. Health-related quality of life showed con-Health-related quality of life showed consistent improvements over time in both sistent improvements over time in both groups, but there were no between-group groups, but there were no between-group differences. Although improvements were differences. Although improvements were evident in the group as a whole (mean evident in the group as a whole (mean baseline EQ-5D self-rated health status baseline EQ-5D self-rated health status score 57, increasing to 72 at 28 weeks), score 57, increasing to 72 at 28 weeks), these participants were still reporting scores these participants were still reporting scores lower than the UK population norm for lower than the UK population norm for 5 2 4 5 2 4 AUTHOR'S PROOF AUTHOR'S PROOF 
Costs and cost-effectiveness Costs and cost-effectiveness
The CBT plus SSRIs group was more The CBT plus SSRIs group was more expensive over the 28-week follow-up than expensive over the 28-week follow-up than the SSRIs group, but not significantly so. the SSRIs group, but not significantly so.
However, the addition of the cost of parti-However, the addition of the cost of participants failing to attend sessions and the cipants failing to attend sessions and the cost of supervisors' time increased this cost cost of supervisors' time increased this cost difference to the extent that the CBT plus difference to the extent that the CBT plus SSRIs group became significantly more SSRIs group became significantly more expensive in both analyses. Since the cost expensive in both analyses. Since the cost of supervisors' time is a realistic cost to of supervisors' time is a realistic cost to include, these results strongly suggest that include, these results strongly suggest that CBT plus SSRIs is significantly more CBT plus SSRIs is significantly more expensive than SSRIs alone. expensive than SSRIs alone. Cost-effectiveness analysis further em-Cost-effectiveness analysis further emphasised the lack of evidence in favour of phasised the lack of evidence in favour of CBT plus SSRIs. Irrespective of the measure CBT plus SSRIs. Irrespective of the measure of outcome chosen, there was no evidence of outcome chosen, there was no evidence to support the hypothesis that CBT plus to support the hypothesis that CBT plus SSRIs is a more cost-effective strategy than SSRIs is a more cost-effective strategy than SSRIs alone for adolescents with major SSRIs alone for adolescents with major depression in receipt of routine care. Cost-depression in receipt of routine care. Costeffectiveness acceptability curves suggest effectiveness acceptability curves suggest that there is at best a 26% probability that that there is at best a 26% probability that CBT plus SSRIs is more cost-effective than CBT plus SSRIs is more cost-effective than SSRIs alone in terms of the HoNOSCA SSRIs alone in terms of the HoNOSCA and only a 4% probability in terms of and only a 4% probability in terms of QALYs. Even when the two participants QALYs. Even when the two participants receiving CBT plus SSRIs who spent most receiving CBT plus SSRIs who spent most of the trial in hospital were excluded in an of the trial in hospital were excluded in an attempt to bias the results in favour of attempt to bias the results in favour of CBT plus SSRIs, the probability of being CBT plus SSRIs, the probability of being cost-effective remained less than 50%. cost-effective remained less than 50%. Thus, the sensitivity of the cost results to Thus, the sensitivity of the cost results to changes in the assumptions upon which changes in the assumptions upon which the costs are based did not alter the overall the costs are based did not alter the overall findings. findings.
Limitations Limitations
Analysis of participants excluded owing to Analysis of participants excluded owing to missing economic data found a significant missing economic data found a significant centre difference, with a higher proportion centre difference, with a higher proportion of missing data in Manchester than Cam-of missing data in Manchester than Cambridge. However, follow-up rates were rela-bridge. However, follow-up rates were relatively high overall (90%) and there is no tively high overall (90%) and there is no evidence to suggest the comparison of the evidence to suggest the comparison of the two groups was biased as a result of two groups was biased as a result of missing data. Despite intensive efforts to missing data. Despite intensive efforts to maintain therapeutic contact, mean attend-maintain therapeutic contact, mean attendance rates for CBT were low (11 out of 19 ance rates for CBT were low (11 out of 19 sessions), which may have reduced the sessions), which may have reduced the response. However, this was a pragmatic response. However, this was a pragmatic trial and these rates reflect the clinical trial and these rates reflect the clinical reality of attendance in this population of reality of attendance in this population of young people. The results are unable to young people. The results are unable to provide evidence of the relative cost-effec-provide evidence of the relative cost-effectiveness of CBT only; however, it was not tiveness of CBT only; however, it was not considered appropriate to deny SSRIs to a considered appropriate to deny SSRIs to a population with such severe illness, given population with such severe illness, given the existence of evidence to support their the existence of evidence to support their effectiveness, particularly for fluoxetine effectiveness, particularly for fluoxetine (Emslie (Emslie et al et al, 1997; Whittington , 1997; Whittington et al et al, , 2004) . The results presented here are 2004). The results presented here are short-term, covering only the 28-week short-term, covering only the 28-week treatment period. The longer-term impact treatment period. The longer-term impact of the interventions is unknown. of the interventions is unknown.
Other evidence Other evidence
Despite these limitations, this study presents Despite these limitations, this study presents the only evidence of the cost-effectiveness of the only evidence of the cost-effectiveness of combination therapy for a pragmatic sample combination therapy for a pragmatic sample of adolescents with major depression. One of adolescents with major depression. One similar study carried out in the USA similar study carried out in the USA explored the use of health services (Clarke explored the use of health services (Clarke et al et al, 2005) , providing some indication of , 2005), providing some indication of resource implications. The study evaluated resource implications. The study evaluated a collaborative care, CBT programme for a collaborative care, CBT programme for adolescents with major depressive disorder adolescents with major depressive disorder as an addition to treatment as usual as an addition to treatment as usual 5 2 5 5 2 5 AUTHOR'S PROOF AUTHOR'S PROOF (consisting primarily of SSRIs) and found (consisting primarily of SSRIs) and found significantly fewer out-patient visits and a significantly fewer out-patient visits and a lower use of medications in the CBT group lower use of medications in the CBT group compared with treatment as usual. How-compared with treatment as usual. However, since service use was not costed, it is ever, since service use was not costed, it is not possible to determine whether these not possible to determine whether these resource use differences would have resource use differences would have translated into significant cost differences. translated into significant cost differences.
Only one cost-effectiveness analysis of Only one cost-effectiveness analysis of individual treatments was located (Haby individual treatments was located (Haby et al et al, 2004) . Haby , 2004) . Haby et al et al, undertook a , undertook a modelling exercise to explore the cost-modelling exercise to explore the costeffectiveness of CBT and SSRIs, both effectiveness of CBT and SSRIs, both compared with current practice. They con-compared with current practice. They concluded that CBT provided by a public psy-cluded that CBT provided by a public psychologist was the most cost-effective chologist was the most cost-effective option for the first-line treatment of major option for the first-line treatment of major depressive disorders. However, this study depressive disorders. However, this study was based on many assumptions and data was based on many assumptions and data from sources of varying quality, including from sources of varying quality, including expert opinion. The sample was much expert opinion. The sample was much broader than that of the current study, broader than that of the current study, including both children and adolescents, including both children and adolescents, and the economic perspective was much and the economic perspective was much narrower, including only the cost of the narrower, including only the cost of the interventions. Although providing the only interventions. Although providing the only other evidence of cost-effectiveness of treat-other evidence of cost-effectiveness of treatments for depression in young people, the ments for depression in young people, the relevance of this Australian modelling study relevance of this Australian modelling study to UK clinical populations is uncertain. to UK clinical populations is uncertain.
Policy implications Policy implications
Guidance for the treatment of depression in Guidance for the treatment of depression in children and adolescents in the UK states children and adolescents in the UK states that antidepressant medication should not that antidepressant medication should not be offered to children or young people with be offered to children or young people with moderate or severe major depression except moderate or severe major depression except in combination with a concurrent psycholo-in combination with a concurrent psychological therapy (National Collaborating gical therapy (National Collaborating Centre for Mental Health, 2005) . For Centre for Mental Health, 2005) . For adolescents in receipt of routine specialist adolescents in receipt of routine specialist clinical care, the results of the ADAPT trial clinical care, the results of the ADAPT trial do not support the combination of CBT do not support the combination of CBT and antidepressants over antidepressants and antidepressants over antidepressants alone, either in terms of effectiveness or alone, either in terms of effectiveness or cost-effectiveness, over the short to medium cost-effectiveness, over the short to medium term. The findings suggest that the provi-term. The findings suggest that the provision of SSRIs in addition to routine care sion of SSRIs in addition to routine care has a higher probability of improving out-has a higher probability of improving outcomes in a cost-effective manner over the comes in a cost-effective manner over the first 6 months of treatment. This finding first 6 months of treatment. This finding was robust to changes in the underlying was robust to changes in the underlying cost assumptions and, given the pragmatic cost assumptions and, given the pragmatic nature of the trial, is generalisable to nature of the trial, is generalisable to clinical samples of adolescents with major clinical samples of adolescents with major depression in the UK. depression in the UK. 
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